T. Rowe Price Investment Management, Inc. Abbott Laboratories Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,730,388 shares of ABT stock, worth $204 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,730,388
Previous 140,542
1131.22%
Holding current value
$204 Million
Previous $14.6 Million
1250.88%
% of portfolio
0.12%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.8 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.03 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.74 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.28 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $206B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...